HAEMORRHAGIC CYSTITIS AFTER LONG TERM, LOW DOSE CYCLOPHOSPHAMIDE Newsletter Article 12 February 2013 Pages: 7 - 7
AVOID NON-ESSENTIAL OESTROGENS IN PROSTHETIC HEART VALVE PATIENTS Newsletter Article 12 February 2013 Pages: 7 - 7
CIMETIDINE CONFIRMS ITS ROLE IN PREVENTING RELAPSE OF PEPTIC ULCERS Newsletter Article 12 February 2013 Pages: 8 - 8
A NEW NON-STEROIDAL ANTI-INFLAMMATORY AGENT — FENBUFEN Newsletter Article 12 February 2013 Pages: 8 - 9
BUPRENORPHINE ANALGESIC: A RECENT INTRODUCTION IN UK Newsletter Article 12 February 2013 Pages: 9 - 9
ERYTHROMYCIN EXTENDS ITS USEFUL RANGE OF ACTIVITY? Newsletter Article 12 February 2013 Pages: 10 - 10
MEZLOCILLIN FOR GONORRHOEA — 98% CURE IN UNCOMPLICATED CASES Newsletter Article 12 February 2013 Pages: 10 - 10
DIALYSIS AND PLASMAPHERESIS FOR INTRACTRACTABLE PROBLEMS Newsletter Article 12 February 2013 Pages: 11 - 11
CEFOTAXIME successful in gonococcal vulvovaginitis in a child Newsletter Article 12 February 2013 Pages: 13 - 13
MIDAZOLAM MALEATE: A better agent for anaesthetic induction Newsletter Article 12 February 2013 Pages: 13 - 13
BM 15,100: An oral antiasthma agent with a long action Newsletter Article 12 February 2013 Pages: 13 - 13
WHEN PRETERM INFANTS ARE GIVEN INDOMETHACIN FOR PDA — Newsletter Article 12 February 2013 Pages: 14 - 14
THE CROSSOVER TRIAL — IS ITS CLINICAL FACADE STARTING TO CRACK? Newsletter Article 12 February 2013 Pages: 14 - 14
ERYTHROCYTE: PLASMA LITHIUM RATIOS REMAIN CONTROVERSIAL Newsletter Article 12 February 2013 Pages: 15 - 15
DOSE OF TOLMETIN CAN BE REDUCED WHEN GIVEN WITH PARACETAMOL Newsletter Article 12 February 2013 Pages: 15 - 15
KINETICS OF CANCER DRUGS: RELEVANCE TO THERAPEUTIC EFFECT Newsletter Article 12 February 2013 Pages: 15 - 15
CHLORAMPHENICOL HALF-LIFE IS PROLONGED BY PARACETAMOL Newsletter Article 12 February 2013 Pages: 16 - 16